State Street’s Nobilis Health Corp. HLTH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q2
Sell
-779,568
Closed -$1.33M 3764
2017
Q1
$1.33M Sell
779,568
-42,424
-5% -$88.2K ﹤0.01% 3206
2016
Q4
$1.73M Buy
821,992
+61,191
+8% +$167K ﹤0.01% 3150
2016
Q3
$2.55M Buy
760,801
+209,366
+38% +$629K ﹤0.01% 2876
2016
Q2
$1.23M Buy
551,435
+96,023
+21% +$311K ﹤0.01% 3213
2016
Q1
$1.42M Buy
455,412
+48,132
+12% +$124K ﹤0.01% 3115
2015
Q4
$1.15M Buy
407,280
+64,708
+19% +$207K ﹤0.01% 3185
2015
Q3
$1.79M Buy
342,572
+96,804
+39% +$556K ﹤0.01% 3035
2015
Q2
$1.67M Buy
+245,768
New +$1.74M ﹤0.01% 3123

Other funds holding HLTH

State Street's HLTH Position: Q2 2017 in Review

State Street sold out of Nobilis Health Corp. (HLTH) in Q2 2017, closing a stake of 779,568 shares — an estimated $1.33M sold.

State Street first reported a position in HLTH in Q2 2015 and held it in 8 quarters. The position peaked at $2.55M in Q3 2016. 49 funds tracked by Wall St. Rank hold HLTH as of Q2 2017.

  • State Street reported no remaining Nobilis Health Corp. position as of Q2 2017 after selling out during the quarter.
  • State Street sold 779,568 Nobilis Health Corp. shares in Q2 2017, an estimated $1.33M.
  • State Street first reported a position in Nobilis Health Corp. in Q2 2015 and held it in 8 quarters.
  • State Street's Nobilis Health Corp. position peaked at $2.55M in Q3 2016.
  • 49 funds tracked by Wall St. Rank held Nobilis Health Corp. as of Q2 2017.

Based on State Street's 13F filing for Q2 2017, filed 14 Aug 2017.